Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Spinal Muscular Atrophy - I, II, and III Center for Genetics at Saint Francis Saint Francis Hospital United States | 3 | 1 |
|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Carrier Screening - Spinal Muscular Atrophy (SMN1) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 216 |
|
Spinal Muscular Atrophy (SMA) Dosage Analysis Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 2 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 8 | 26 |
|
Spinal muscular atrophy type 1 (SMN1 gene) Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile | 1 | 1 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 73 | 61 |
|
Survival motor neuron 1 (SMN1) and 2 (SMN2) gene dosage evaluation by MLPA analysis Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 164 |
|
Carrier Screening Ashkenazi Jewish Panel Ambry Genetics United States | 51 | 47 |
|
Ambry Genetics United States | 4 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 2 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.